These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 16445417)

  • 21. Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis.
    Gottlieb A; Feng J; Harrison DJ; Globe D
    J Am Acad Dermatol; 2010 Oct; 63(4):580-6. PubMed ID: 20599294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of psoriasis with etanercept in a patient with a history of primary B-cell lymphoma.
    Chong BF; Wong HK
    Clin Exp Dermatol; 2009 Jul; 34(5):e11-3. PubMed ID: 19040508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etanercept and demyelinating disease in a patient with psoriasis.
    Sukal SA; Nadiminti L; Granstein RD
    J Am Acad Dermatol; 2006 Jan; 54(1):160-4. PubMed ID: 16384777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 25. Managing pediatric patients with psoriasis.
    Bard S; Torchia D; Schachner LA
    Am J Clin Dermatol; 2010; 11 Suppl 1():15-7. PubMed ID: 20586500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent etanercept therapy in pediatric patients with psoriasis.
    Siegfried EC; Eichenfield LF; Paller AS; Pariser D; Creamer K; Kricorian G
    J Am Acad Dermatol; 2010 Nov; 63(5):769-74. PubMed ID: 20833444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
    Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
    Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etanercept in psoriasis treatment.
    Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Puerto Rico psoriasis study group: efficacy and safety of etanercept.
    González-Chavez JR; Berlingeri-Ramos AC; Sánchez Casiano MA
    J Drugs Dermatol; 2005; 4(6):735-9. PubMed ID: 16302559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term etanercept in pediatric patients with plaque psoriasis.
    Paller AS; Siegfried EC; Eichenfield LF; Pariser D; Langley RG; Creamer K; Kricorian G
    J Am Acad Dermatol; 2010 Nov; 63(5):762-8. PubMed ID: 20605256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Juvenile generalized pustular psoriasis treated with etanercept.
    Fialová J; Vojáčková N; Vaňousová D; Hercogová J
    Dermatol Ther; 2014; 27(2):105-8. PubMed ID: 24703268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etanercept for psoriasis: two case reports.
    Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
    Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etanercept therapy in patients with autoimmunity and hepatitis C.
    Khanna M; Shirodkar MA; Gottlieb AB
    J Dermatolog Treat; 2003 Dec; 14(4):229-32. PubMed ID: 14660270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy.
    Zachariae C; Mørk NJ; Reunala T; Lorentzen H; Falk E; Karvonen SL; Johannesson A; Claréus B; Skov L; Mørk G; Walker S; Qvitzau S
    Acta Derm Venereol; 2008; 88(5):495-501. PubMed ID: 18779890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etanercept for the treatment of severe childhood psoriasis.
    Papoutsaki M; Costanzo A; Mazzotta A; Gramiccia T; Soda R; Chimenti S
    Br J Dermatol; 2006 Jan; 154(1):181-3. PubMed ID: 16403117
    [No Abstract]   [Full Text] [Related]  

  • 36. Etanercept in the treatment and retreatment of psoriasis in daily clinical practice.
    Barrera MV; Habicheyn S; Mendiola MV; Herrera Ceballos E
    Eur J Dermatol; 2008; 18(6):683-7. PubMed ID: 19049936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
    Gerloni V; Pontikaki I; Gattinara M; Fantini F
    Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade).
    Thielen AM; Barde C; Marazza G; Saurat JH
    Dermatology; 2008; 217(2):137-9. PubMed ID: 18503258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recalcitrant palmoplantar pustular psoriasis treated with etanercept.
    Floristan U; Feltes R; Ramírez P; Alonso ML; De Lucas R
    Pediatr Dermatol; 2011; 28(3):349-50. PubMed ID: 21371112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etanercept: An overview.
    Goffe B; Cather JC
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S105-11. PubMed ID: 12894133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.